OCULAR THERAPEUTIX, INC (OCUL)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenue, net | 13,459 | 10,698 | 15,425 | 16,441 |
| Selling and marketing | 13,729 | 14,148 | 10,573 | 9,994 |
| Research and development | 51,081 | 42,857 | 37,054 | 28,857 |
| General and administrative | 14,346 | 16,348 | 12,235 | 19,671 |
| Cost of product revenue | 1,944 | 1,262 | 1,561 | 1,509 |
| Total costs and operating expenses | 81,100 | 74,615 | 61,423 | 60,031 |
| Loss from operations | -67,641 | -63,917 | -45,998 | -43,590 |
| Interest income | 3,455 | 3,826 | 5,653 | 6,036 |
| Interest expense | 3,016 | 2,984 | 3,224 | 3,196 |
| Gain on disposal of items of property and equipment | 29 | - | - | - |
| Change in fair value of derivative liabilities | -641 | -978 | 7,076 | -3,027 |
| Total other expense, net | -173 | -136 | 9,505 | -187 |
| Net loss | -67,814 | -64,053 | -36,493 | -43,777 |
| Earnings per share, basic | -0.39 | -0.38 | -0.22 | -0.26 |
| Earnings per share, diluted | -0.39 | -0.38 | -0.22 | -0.26 |
| Weighted average number of shares outstanding, basic | 172,594,662 | 169,396,989 | 166,992,735 | 165,824,778 |
| Weighted average number of shares outstanding, diluted | 172,594,662 | 169,396,989 | 166,992,735 | 165,824,778 |